PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Endocrinology, Department of Medicine and Sciences of Aging, and Center for Advanced Science and Technology (CAST), University of Chieti-Pescara, Chieti, Italy. Electronic address: cesidio.giuliani@unich.it.\', \'Unit of Endocrinology, Department of Medicine and Sciences of Aging, and Center for Advanced Science and Technology (CAST), University of Chieti-Pescara, Chieti, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0306-9877(20)33364-810.1016/j.mehy.2020.110473
?:doi
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 33385879
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced \'cytokines storm\'.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all